| Customization: | Available |
|---|---|
| Treatment: | Nutrition |
| Transport Package: | Carton |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Moxifloxacin is indicated in adult patients for the treatment of Community Acquired Pneumonia caused by susceptible isolates of Streptococcus pneumoniae (including multi-drug resistant Streptococcus pneumoniae [MDRSP]), Haemophilus influenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, or Chlamydophila pneumoniae.
){kind=link}